Simplify Presents Six-figure Check to Susan G. Komen®, Marking One Year Since the Launch of the Simplify Health Care ETF (PINK)
PINK, the first pro bono ETF, donates all net profits to Susan G. Komen, the leading breast cancer organization. On its one-year anniversary, Simplify Asset Management presented a $100,000 check to Komen, symbolizing its commitment.
This donation stems from profits made in managing the Simplify Health Care ETF (PINK).
PINK is actively managed by seasoned investor Michael Taylor, focusing on investments in biotechnology and the healthcare industry.
- $100,000 donation to Susan G. Komen marks one year of PINK ETF management.
- PINK ETF promotes social responsibility by donating all profits.
- Experienced management under Michael Taylor enhances investor confidence.
- PINK ETF has a limited operating history, which may present investment risk.
- Focus on the biotechnology sector exposes investors to regulatory and patent risks.
PINK, the first pro bono ETF, is designed so all of Simplify’s net profits from managing the fund are donated on an annual basis to Komen, the world’s leading breast cancer organization
Simplify CEO
This donation represents Simplify’s profits from one year of managing the PINK ETF, as this fund is designed so all such profits are donated to
The presentation is taking place today at Simplify’s 2nd annual Entering the
PINK is an actively managed fund overseen by renowned hedge fund investor
"Our partnership with Simplify through the
“We are honored to be presenting our friends at Susan G. Komen with this donation,” said
MORE THAN PINK Walk
Simplify is a sponsor for the 2022 Komen OC MORE THAN PINK Walk and is participating with a Walk Team.
“We’re incredibly grateful for Simplify Asset Management for being a local sponsor of the Orange County MORE THAN PINK Walk and participating as a Walk Team. The Orange County MORE THAN PINK Walk raises funds to support Komen’s work in research and patient care services that are important to our community. The demand for our services is greater than ever and it is only through the support of our partners, like Simplify Asset Management, that we can provide support to the women and men facing breast cancer and metastatic breast cancer,” said
For more information on PINK and the Fund’s efforts to support
ABOUT SIMPLIFY ASSET MANAGEMENT INC.
ABOUT
Investors should carefully consider the investment objectives, risks, charges and expenses of Exchange Traded Funds (ETFs) before investing. To obtain an ETF's prospectus containing this and other important information, please call (855) 772-8488, or visit SimplifyETFs.com. Please read the prospectus carefully before you invest. An investment in the fund involves risk, including possible loss of principal. Past performance does not guarantee future results.
The fund is new and has a limited operating history.
The Fund focuses its investments in securities of biotechnology and the healthcare industry. Economic, legislative or regulatory developments may occur that significantly affect these industries and cause the Fund’s net asset value to fluctuate due to this concentration.
The biotechnology industry can be significantly affected by patent considerations, including the termination of patent protections for products, intense competition both domestically and internationally, rapid technological change and obsolescence, government regulation and expensive insurance costs due to the risk of product liability lawsuits.
In addition, the biotechnology industry is an emerging growth industry, and therefore biotechnology companies may be thinly capitalized have limited product lines, distribution channels, resources and more volatile than companies with greater capitalizations. Biotechnology companies must contend with high development costs, which may be exacerbated by the inability to raise prices to cover costs because of managed care pressure, government regulation or price controls. Companies in the pharmaceutical industry are heavily dependent on patent protection. The expiration of patents may adversely affect the profitability of the companies. Pharmaceutical companies are also subject to extensive litigation based liability and approval of the
The Fund’s focus on the healthcare sector may cause its value to fluctuate and be more susceptible to particular risks of the sector such as extensive government regulations, restrictions on government reimbursement for medical expenses, rising costs of medical products and services, pricing pressure, an increased emphasis on outpatient services, changes in the demand for medical products and services, a limited number of products, industry innovation, changes in technologies and other market developments.
Simplify ETFs are distributed by
View source version on businesswire.com: https://www.businesswire.com/news/home/20221012005705/en/
(212) 473-4442
chris@macmillancom.com
Source:
FAQ
What is the purpose of the Simplify Health Care ETF (PINK)?
How much did Simplify donate to Susan G. Komen?
Who manages the Simplify Health Care ETF (PINK)?
What are the risks associated with investing in the PINK ETF?